Clinical Trials

    Phase I Trial Evaluating the Safety of the Dietary Supplement Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer

    Investigator: Jun Zhang

    Study Coordinator: Derek Cole

    Status: Enrolling

    ClinicalTrials.gov Number: NCT06566443

    Phone: 713.441.5607

    Protocol Number: PRO00037422

    Description


    The goal of this research study is to find the highest, safest dose of honokiol (a type of dietary supplement) that can be given to patients who have resectable early-stage NSCLC. Researchers also want to learn if giving honokiol before surgery can help to control the tumor.